SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Jindřich Činátl, Hanibal Bohnenberger et al.|Nature Medicine|2016Cited by 185
Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus researchFranziska Hufsky, Joshua B. Singer, Kevin Lamkiewicz et al.|Briefings in Bioinformatics|2020Cited by 149
Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research. (Specia Issue: Bioinformatics helping to mitigate the impact of COVID-19.)Franziska Hufsky, Kristof Theys, Kevin Lamkiewicz et al.|Briefings in Bioinformatics|2021Cited by 0